Physician profile
Phillip B Mann
NPI 1215425871
$1,698.75
in general payments reported to CMS, 2019-2025
34 companies · $770 in 2025
The $770 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $162 · 2024: $767 · 2025: $770.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,699.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,698.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $276.62 | 2023-2025 | |
| Urogen Pharma, INC. | $148.55 | 2024-2025 | |
| Pfizer INC. | $147.34 | 2023-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $96.03 | 2024-2025 | |
| Olympus America INC. | $77.31 | 2024-2025 | Itind System |
| Astellas Pharma US INC | $67.28 | 2024-2025 | Xtandi, Myrbetriq |
| Sumitomo Pharma America, INC. | $60.70 | 2023-2025 | Orgovyx |
| Novartis Pharmaceuticals Corporation | $59.92 | 2024-2025 | |
| Teleflex LLC | $56.63 | 2024-2025 | Urolift, Deflux Metal Needle |
| Boston Scientific Corporation | $56.47 | 2025 | Spaceoar System, Spaceoar Vue System - 10ml, Accolade Sr |
| Merck Sharp & Dohme LLC | $55.71 | 2023-2025 | Keytruda, Lynparza |
| Ferring Pharmaceuticals INC. | $47.91 | 2024 | Adstiladrin |
| Accord Healthcare, INC. | $47.57 | 2024 | |
| Janssen Biotech, INC. | $47.26 | 2025 | Erleada |
| Coloplast Corp | $46.33 | 2024-2025 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $43.93 | 2024 | Trumatch, Matrixmandible, Matrixmidface |
| Endo USA, INC. | $39.48 | 2025 | Xiaflex |
| Procept Biorobotics Corporation | $35.24 | 2024-2025 | Aquabeam System |
| Calyxo, INC. | $24.59 | 2024 | Cvac Aspiration System |
| Cycle Pharmaceuticals INC | $24.17 | 2025 | Venxxiva |
| Progenics Pharmaceuticals, INC. | $24.08 | 2024 | |
| Endo Pharmaceuticals INC. | $20.50 | 2023 | Xiaflex |
| Vertex Pharmaceuticals Incorporated | $19.56 | 2025 | |
| Tolmar, INC. | $18.58 | 2024 | |
| Medtronic, INC. | $18.33 | 2024 | Interstim |
| Sagent Pharmaceuticals | $17.69 | 2024 | Glydo |
| Immunitybio, INC. | $17.09 | 2024 | |
| Axonics, INC. | $17.02 | 2024 | Axonics |
| Valencia Technologies Corporation | $15.47 | 2025 | Ecoin Device Kit |
| Telix Pharmaceuticals | $15.44 | 2025 | Illuccix |
| Photocure INC | $15.27 | 2023 | Cysview |
| Verity Pharmaceuticals INC. | $13.70 | 2025 | Trelstar |
| Myriad Genetic Laboratories, INC. | $13.50 | 2024 | Prolaris |
| Laborie Medical Technologies Corp. | $13.48 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Phillip Mann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.